AC Immune SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 2836 www.acimmune.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

INSM Stock Slides on CFO Exit, Reiterates '26 Sales View - Oct 6th, 2026 8:29 am
AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know - Oct 6th, 2026 7:55 am
PCRX Expands Exparel Commercial Reach in Europe Through Molteni Deal - Oct 6th, 2026 7:30 am
Novartis Strengthens RNA Therapeutics Pipeline With $7.8B Abogen Deal - Oct 5th, 2026 9:21 am
Ultragenyx's Gene Therapy for Sanfilippo Syndrome Wins EMA Validation - Oct 5th, 2026 8:46 am
Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work - Oct 5th, 2026 8:36 am
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - Oct 1st, 2026 9:16 am
Novo's Wegovy Pill Shows Weight Loss After Switching From Injections - Oct 1st, 2026 7:42 am
Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study - Oct 1st, 2026 6:55 am
NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk - Sep 30th, 2026 11:34 am
uniQure Plunges on Additional Data From Huntington's Disease Study - Sep 30th, 2026 10:47 am
IOVA Stock Hits 52-Week High on Raised Revenue Outlook for 2026 - Sep 30th, 2026 7:22 am
Here's Why You Should Add URGN Stock to Your Portfolio Now - Sep 30th, 2026 7:11 am
Best Momentum Stock to Buy for September 30th - Sep 30th, 2026 4:43 am
AbbVie Wins FDA Nod for New Parkinson's Disease Drug Juvmo - Sep 29th, 2026 9:37 am
KOD Stock Soars 178% on Positive Wet AMD Data as BLA Filing Nears - Sep 29th, 2026 8:13 am
Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline - Sep 29th, 2026 8:12 am
Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041 - Sep 29th, 2026 7:06 am
Teva's Branded Drugs Take Center Stage in Its Growth Strategy - Sep 29th, 2026 5:50 am
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication - Sep 28th, 2026 9:04 am